Private Capital Group’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Private Capital Group’s Portfolio EPRS Stock Details EPRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-400	Closed	–	–	2363
2019 Q3	$0	Buy	+400	New	–	﹤0.01%	2657

Private Capital Group's EPRS Position: Q4 2019 in Review

Private Capital Group sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q4 2019, closing a stake of 400 shares.

Private Capital Group first reported a position in EPRS in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 0 funds tracked by Wall St. Rank hold EPRS as of Q4 2019.

Private Capital Group reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q4 2019 after selling out during the quarter.
Private Capital Group sold 400 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q4 2019.
Private Capital Group first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q3 2019 and held it in 1 quarter.
Private Capital Group's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $0 in Q3 2019.
0 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q4 2019.

Based on Private Capital Group's 13F filing for Q4 2019, filed 14 Feb 2020.